BAA-009
BAA-009 is a selective and orally active PKMYT1 inhibitor with an IC50 of <50 nM. BAA-009 inhibits cancer cells proliferation and inhibits tumor growth in OVCAR3 xenograft mice. BAA-009 can be used for the research of cancer, such as ovarian cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C28H35N5O4S
- Molecular Weight:537.67
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
|
PKMYT1 <50 nM (IC50) |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:human ovarian cancer OVCAR3 xenograft mice models[1]
-
Dosage:40, 120 mg/kg
-
Administration:p.o.; qd for 17 days
-
Result:Inhibited tumor growth.
Showed stronger antitumor activity combined with Irinotecan (HY-16562) and ADC Mirvetuximab exatecan.
Chemical Information
-
Molecular Weight 537.67
-
Formel C28H35N5O4S
-
SMILES
CC(C)(C)C(OC1=CC=C(C)C(NC(C2=CN=C(NC3=NC(NC(C(C)(C)C)=O)=CC=C3C)S2)=O)=C1C)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
BAA-009 Related Classifications
HY-182791 Related Classifications
Powered by Bioz